Bio-Techne (TECH) Free Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 150.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150.27% |
| Dec 31, 2025 | -1.34% |
| Sep 30, 2025 | -59.39% |
| Jun 30, 2025 | 62.23% |
| Mar 31, 2025 | -51.98% |
| Dec 31, 2024 | 13.59% |
| Sep 30, 2024 | 19.49% |
| Jun 30, 2024 | -20.74% |
| Mar 31, 2024 | 66.41% |
| Dec 31, 2023 | 17.12% |
| Sep 30, 2023 | -1.58% |
| Jun 30, 2023 | -18.60% |
| Mar 31, 2023 | -33.16% |
| Dec 31, 2022 | -35.84% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | -19.47% |
| Mar 31, 2022 | -9.70% |
| Dec 31, 2021 | 16.71% |
| Sep 30, 2021 | -23.07% |
| Jun 30, 2021 | 303.76% |
| Mar 31, 2021 | 59.91% |
| Dec 31, 2020 | 39.33% |
| Sep 30, 2020 | 83.48% |
| Jun 30, 2020 | -38.04% |
| Mar 31, 2020 | 15.69% |
| Dec 31, 2019 | 33.12% |
| Sep 30, 2019 | -14.87% |
| Jun 30, 2019 | -25.02% |
| Mar 31, 2019 | 91.47% |
| Dec 31, 2018 | 27.74% |
| Sep 30, 2018 | -10.56% |
| Jun 30, 2018 | 31.22% |
| Mar 31, 2018 | -13.63% |
| Dec 31, 2017 | -15.29% |
| Sep 30, 2017 | 63.85% |
| Jun 30, 2017 | 33.89% |
| Mar 31, 2017 | -38.77% |
| Dec 31, 2016 | 15.23% |
| Sep 30, 2016 | -6.43% |
| Jun 30, 2016 | 11.22% |
| Mar 31, 2016 | 32.68% |
| Dec 31, 2015 | 3.28% |
| Sep 30, 2015 | -16.55% |
| Jun 30, 2015 | -15.67% |
| Mar 31, 2015 | -15.72% |
| Dec 31, 2014 | 17.74% |
| Sep 30, 2014 | 7.09% |
| Jun 30, 2014 | 45.36% |
| Mar 31, 2014 | 15.09% |
| Dec 31, 2013 | 19.98% |
| Sep 30, 2013 | 7.57% |
| Jun 30, 2013 | -32.08% |
| Mar 31, 2013 | -18.93% |
| Dec 31, 2012 | 26.48% |
| Sep 30, 2012 | -19.76% |
| Jun 30, 2012 | 8.63% |
| Mar 31, 2012 | 3.40% |
| Dec 31, 2011 | -36.50% |
| Sep 30, 2011 | 12.43% |
| Jun 30, 2011 | 8.94% |
| Mar 31, 2011 | 45.50% |
| Dec 31, 2010 | 7.80% |
| Sep 30, 2010 | 7.96% |